FDA — authorised 23 March 2016
- Marketing authorisation holder: TEVA RESPIRATORY LLC
- Status: approved
🇺🇸 Cinqair in United States
FDA authorised Cinqair on 23 March 2016
Marketing authorisations
FDA — authorised 23 March 2016
- Application: BLA761033
- Marketing authorisation holder: TEVA RESPIRATORY LLC
- Local brand name: CINQAIR
- Indication: INJECTABLE — INJECTION
- Status: approved
Cinqair in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Respiratory approved in United States
Frequently asked questions
Is Cinqair approved in United States?
Yes. FDA authorised it on 23 March 2016; FDA authorised it on 23 March 2016.
Who is the marketing authorisation holder for Cinqair in United States?
TEVA RESPIRATORY LLC holds the US marketing authorisation.